Product Information
AFIRMELLE-28 TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1584 per EA under NDC 65862084988. Its NADAC has been published 314 times since Aug 21, 2019.
Manufacturer
Aurobindo Pharma LimitedNDC
65862084988
Classification
Generic
Dosage Form
KIT
Last Updated
8/20/2025
Approval Type
Generic (ANDA)
FDA Application
ANDA206886On Market Since
11/14/2016
Price Statistics
The NADAC for AFIRMELLE-28 TABLET has been published 314 times since Aug 21, 2019, and over the history we have for it it has declined 58.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1584 per EA |
|---|---|
| All-time high | $0.3780 (Sep 11, 2019) |
| All-time low | $0.1212 (Jul 17, 2024) |
| 52-week high | $0.1602 |
| 52-week low | $0.1584 |
| Median price | $0.2057 |
| Average price | $0.2138 |
| Largest weekly change | +35.3% (Jun 19, 2024) |
| Weeks tracked | 314 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 29% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AFIRMELLE-28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AFIRMELLE-28 TABLET, manufactured by Aurobindo Pharma Limited, is $0.1584 per EA (NDC 65862084988), effective Aug 20, 2025.
How has the price of AFIRMELLE-28 TABLET changed over time?
Over the history we have for it, the NADAC for AFIRMELLE-28 TABLET has declined 58.1%. It has been tracked across 314 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for AFIRMELLE-28 TABLET?
Since Aug 21, 2019, the NADAC for AFIRMELLE-28 TABLET has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.3780 (Sep 11, 2019), with a median of $0.2057 per EA.
Are there cheaper alternatives to AFIRMELLE-28 TABLET?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CHATEAL EQ-28 TABLET, is $0.1125 per EA — about 29% below AFIRMELLE-28 TABLET.
Who manufactures AFIRMELLE-28 TABLET?
AFIRMELLE-28 TABLET (NDC 65862084988) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification